Tag Archives: Clean Rooms

May 28, 2008 — /PRNewswire/ — ATLANTA, GA — Qcept Technologies Inc., the developer of a new breed of wafer inspection systems for the semiconductor manufacturing industry, announced that it has entered into a cooperative agreement with CEA-Leti, one of the world’s leading research organizations dedicated to the advancement of micro- and nanotechnology. Qcept and CEA-Leti will investigate potential new techniques for characterizing a variety of leading-edge semiconductor materials and processes, including high-k and low-k dielectrics, atomic layer deposition (ALD), fully silicided (FUSI) metal gates, and advanced cleaning technologies.

Under the terms of the agreement, CEA-Leti is providing its extensive know-how in advanced semiconductor process development to the partnership. Qcept, in turn, has installed its ChemetriQ(R) non-visual defect (NVD) wafer inspection technology in CEA-Leti’s development facility in Grenoble, France, where it is augmenting the organization’s existing process characterization capabilities.

“Advanced materials and processes, such as high-k dielectrics and metal gates, have the potential to significantly enhance the performance of future generations of semiconductor devices. However, their complexity can give rise to new and unique yield problems, which require innovative inspection methods,” states Adrien Danel, lead research engineer at CEA-Leti. “This partnership with Qcept can help us to better understand the yield issues surrounding these materials and processes in order to speed their development and integration into full-scale manufacturing.”

“Leti is at the forefront of many critical areas of semiconductor research and development,” states Ralph Spicer, vice president of marketing for Qcept. “Working with CEA-Leti will provide us with a unique opportunity to have early access to these advanced technologies — allowing us to qualify our ChemetriQ solution for some of the industry’s most cutting-edge applications.”

Qcept’s ChemetriQ platform provides rapid, full-wafer, inline detection of NVDs, such as organic and inorganic residue, metallic contaminants, process-induced charging, watermarks, and other non-visual residue defects that are undetectable by optical inspection systems. ChemetriQ accomplishes this by employing an innovative, non-destructive technology that detects work function variations on the surface of semiconductor wafers. The ChemetriQ platform is sensitive to 5E9 atoms/cm2 (one atom out of 200,000 per square centimeter), which exceeds the requirements outlined in the International Technology Roadmap for Semiconductors (ITRS) for metallic contamination detection down to the 22-nm node.

About CEA-Leti
The CEA (French Atomic Energy Commission), a public organization for technological research, carries out its missions in the domains of energy, information and health technologies, and defense, building on the foundations of fundamental research at the highest level. Strengthened by the competence of its 15,000 researchers and collaborators, it is recognized internationally and constitutes a strong source of original ideas for public authorities, institutions and industries in France and throughout Europe.

Located in Grenoble, France, CEA-Leti (Electronics and Information Technology Laboratory of the French Atomic Energy Commission) is at the leading edge of European research in microelectronics, microtechnology and nanotechnology. It employs close to 1,000 people and deposits approximately 200 patents per year. With 28 start-ups created or in the course of creation, it is one of the most important partners of the industrial world. Instigator of the MINATEC(R) pole of innovation, CEA-Leti is also one of its principal partners, alongside of the INP Grenoble (Grenoble Institute of Technology) and local authorities.

Visit www.cea.fr

About Qcept Technologies Inc.
Qcept delivers wafer inspection solutions for non-visual defect (NVD) detection in advanced semiconductor manufacturing. Qcept’s ChemetriQ(R) platform is being adopted in critical processes for inline, non-contact, full-wafer detection of such NVDs as sub-monolayer organic and metallic residues, process-induced charging, and other undesired surface non-uniformities that cannot be detected by conventional optical inspection equipment.

Visit www.qceptech.com

Source: Qcept Technologies Inc.

May 29, 2008 — /PRNewswire/ — MOUNTAIN VIEW, CA — Silecs, Inc., a leading provider of advanced enabling materials to the microelectronics industry, today announced that its high-volume manufacturing facility in Espoo, Finland, has been granted ISO 14001 certification by DNV. This important recognition follows a rigorous review of Silecs’ state-of-the-art facility, designed from the ground up to adhere to the highest possible standards for protecting the environment as well as the health and safety of Silecs’ employees and customers.

The ISO 14001 Standard is an internationally accepted specification for environmental management systems (EMSs), created by the International Organization for Standardization to help organizations minimize how their operations affect the environment and comply with related laws, regulations and requirements. To achieve ISO 14001 certification, companies must establish an EMS and develop an environmental policy for their organization, including setting clear environmental objectives and targets to be met. Moreover, they are expected to regularly monitor and evaluate their EMS to ensure that a high level of overall environmental performance is maintained.

Says Silecs’ vice president of engineering, Billy McLaughlin, “We are fully committed to achieving the highest possible degree of both cleanliness and quality throughout our manufacturing process. Not only are we creating our materials in an environmentally friendly facility, but our products are also contributing to building a new generation of ‘greener electronics’ — something you wouldn’t expect to hear from a company specializing in complex chemistries. That’s why we are particularly gratified to have received this validation of our relentless efforts to be best-in-class in this increasingly critical area.”

Prior to its most recent honor, Silecs’ Espoo facility, including all production, design, development, and test functions, was also certified to be compliant with ISO 9001:2000 standards for quality management.

To learn more about Silecs’ advanced enabling materials, please visit the company at the 2008 IEEE International Interconnect Technology Conference, June 1-4, at the Hyatt Regency, Burlingame, CA.

About Silecs, Inc.
Silecs, Inc. provides advanced enabling materials to the microelectronics industry where they are used primarily in semiconductor, digital image sensor and flat panel display manufacturing, enabling customers to achieve improved device performance and reduced overall production costs. From its state-of-the-art technology and production center in Espoo, Finland, Silecs’ scientists leverage molecular engineering techniques in semiconductor-quality clean-room conditions to develop ultra-high-purity materials based on silicon chemistries.

Source: Silecs, Inc.

Visit www.silecs.com

May 20, 2008 — /SEMI/ — SAN JOSE, CA — North America-based manufacturers of semiconductor equipment posted $1.07 billion in orders in April 2008 (three-month average basis) and a book-to-bill ratio of 0.81, according to the April 2008 Book-to-Bill Report published today by SEMI. A book-to-bill of 0.81 means that $81 worth of orders were received for every $100 of product billed for the month.

The three-month average of worldwide bookings in April 2008 was $1.07 billion. The bookings figure is about 8 percent less than the final March 2008 level of $1.17 billion, and almost 32 percent less than the $1.57 billion in orders posted in April 2007.

The three-month average of worldwide billings in April 2008 was $1.32 billion. The billings figure is about 2 percent less than the final March 2008 level of $1.34 billion, and about 17 percent less than the April 2007 billings level of $1.59 billion.

“Relatively flat bookings and billings for North American semiconductor equipment reflect the continued conservative mood of the industry,” says Stanley T. Myers, president and CEO of SEMI. “A number of fab projects have been put on hold or delayed until 2009, and the current 2008 equipment data reflect this trend.”

The SEMI book-to-bill is a ratio of three-month moving averages of worldwide bookings and billings for North American-based semiconductor equipment manufacturers. Billings and bookings figures are in millions of U.S. dollars (click here to view table on SEMI’s site).

The data contained in this release was compiled by David Powell, Inc., an independent financial services firm, without audit, from data submitted directly by the participants. SEMI and David Powell, Inc. assume no responsibility for the accuracy of the underlying data.

The data are contained in a monthly Book-to-Bill Report published by SEMI. The report tracks billings and bookings worldwide of North American-headquartered manufacturers of equipment used to manufacture semiconductor devices, not billings and bookings of the chips themselves.

About SEMI
SEMI is the global industry association serving the manufacturing supply chains for the microelectronic, display and photovoltaic industries. SEMI member companies are the engine of the future, enabling smarter, faster, and more economical products that improve our lives. Since 1970, SEMI has been committed to helping members grow more profitably, create new markets, and meet common industry challenges. SEMI maintains offices in Austin, Beijing, Brussels, Hsinchu, Moscow, San Jose, Seoul, Shanghai, Singapore, Tokyo, and Washington, D.C.

Visit www.semi.org

May 20, 2008 — Polypore International, Inc. today announced that through its wholly owned subsidiary, Celgard, LLC, the company has closed on the previously announced acquisition of 100 percent of the outstanding capital stock of Yurie-Wide Corp., a South Korean company, for approximately $23 million in cash, including acquisition-related costs.

About Polypore International, Inc.
Polypore International, Inc. is a global high-technology filtration company specializing in microporous membranes. Polypore’s flat sheet and hollow fiber membranes are used in specialized applications that require the removal or separation of various materials from liquids, primarily in the ultrafiltration and microfiltration markets. Based in Charlotte, NC, Polypore International, Inc. is a market leader with manufacturing facilities or sales offices in ten countries serving six continents.

Visit www.polypore.net

About Celgard, LLC
Celgard, LLC — part of Polypore’s Energy Storage business segment — is a global leader in the development and production of specialty microporous membranes, including separators used in rechargeable lithium-ion batteries for personal electronic devices such as notebook computers, mobile telephones, digital cameras, and other high performance applications such as power tools, hybrid-electric vehicles (HEVs) and fuel cells. A key component in lithium-ion batteries, the separator is an ultra-thin microporous plastic membrane that separates the battery’s positive and negative electrodes and facilitates ion flow.

Visit www.celgard.com

May 20, 2008 — /PRNewswire/ — MOFFETT FIELD, CA — NASA has developed a revolutionary nanotechnology-based biosensor that can detect trace amounts of specific bacteria, viruses, and parasites. This biosensor will be used to help prevent the spread of potentially deadly biohazards in water, food, and other contaminated sources.

NASA’s Ames Research Center at Moffett Field in California licensed the biosensor technology to Early Warning Inc., Troy, NY. Under a Reimbursable Space Act Agreement, NASA and Early Warning jointly will develop biosensor enhancements. Initially, the biosensor will be configured to detect the presence of common and rare strains of microorganisms associated with water-borne illnesses and fatalities.

“The biosensor makes use of ultra-sensitive carbon nanotubes which can detect biohazards at very low levels,” explains Meyya Meyyappan, chief scientist for exploration technology and former director of the Center for Nanotechnology at Ames. “When biohazards are present, the biosensor generates an electrical signal, which is used to determine the presence and concentration levels of specific microorganisms in the sample. Because of their tiny size, millions of nanotubes can fit on a single biosensor chip.”

Early Warning company officials say food and beverage companies, water agencies, industrial plants, hospitals, and airlines could use the biosensor to prevent outbreaks of illnesses caused by pathogens — without needing a laboratory or technicians.

“Biohazard outbreaks from pathogens and infectious diseases occur every day in the U.S. and throughout the world,” says Neil Gordon, president of Early Warning. “The key to preventing major outbreaks is frequent and comprehensive testing for each suspected pathogen, as most occurrences of pathogens are not detected until after people get sick or die. Biohazards can enter the water supply and food chain from a number of sources, which are very difficult to uncover.

Early Warning expects to launch its water-testing products in late 2008.

“Ambitious space missions have produced some of the world’s most creative technologies by NASA and its industrial partners,” says Harry Partridge, deputy director of the Space Technologies Division at Ames. “Not only does NASA want these technologies used in space applications, an equally important objective is the transition of NASA research into real world products that can benefit our society.”

Source: NASA

Visit http://ipp.nasa.gov/

Visit www.earlywarninginc.com

May 21, 2008 — ROLLING MEADOWS, IL — The Institute of Environmental Sciences and Technology (IEST) is pleased to announce its new officers for the term beginning July 1, 2008.

Charles W. Berndt moves from the position of president-elect to IEST president. A Fellow of IEST, Berndt is involved in many ESTECH and Working Group activities. He is the principal in C.W. BERNDT Associates. Berndt spent six years as group manager of the Araclean Division of ARA/Aratex Services (now known as ARAMARK Cleanroom Services) and holds a bachelor’s degree in chemistry-biology from Roosevelt University in Chicago. He serves on the editorial advisory board of CleanRooms magazine.

Other new officers are: Michael Rataj, president-elect; Greg Winn, membership vice president; Roger Diener, education vice president (Contamination Control); and Christine Peterson, technical vice president (Design, Test, and Evaluation/Product Reliability).

Mike Rataj has been involved in the contamination control industry for 12 years since taking over as QA manager for ARAMARK’s Chicago cleanroom plant. Rataj holds an MS in biology from the University of Illinois and an MBA in operations management from the Illinois Institute of Technology Stuart School of Business. He has served as IEST membership vice president and is chair of Working Groups CC003 and CC023.

Greg Winn is general manager for White Knight Engineered Products Controlled Environments Division. His career has encompassed business and product development for industrial machinery, hardware, and software for analytical laboratory equipment, as well as environmental testing as a methods development chemist. Winn is a member of Working Group CC003: Garment System Considerations for Cleanrooms and Other Controlled Environments.

Roger Diener is a senior member of IEST and the recipient of IEST’s James R. Mildon Award in 2003. He has served as president and vice president of the New England Chapter. His practical experience in protocol development and manufacturing operations engineering has allowed him to actively contribute in the development of many IEST Recommended Practices.

Christine Peterson has almost two decades of experience in testing, ranging from helping to write original specifications (or updating existing ones) to running the tests herself, along with teaching the topic worldwide. Peterson previously served as IEST communications vice president and has been an ESTECH seminar chair (or co-chair) and IEST Working Group member. She also has served as chair for IEC/TC 104 MT 16 and chair for ISO/TC 108, SC 6.

Remaining on the executive board are R.Vijayakumar, fiscal vice president; David Ball, education vice president (Design, Test, and Evaluation/Product Reliability); Gregg Mosley, communications vice president; Gary Knoth, technical vice president (Contamination Control); and Fred Fey, immediate past president.

About IEST
Founded in 1953, IEST is an international not-for-profit technical society of engineers, scientists, and educators that serves its members and the industries they represent (simulating, testing, controlling, and teaching the environments of earth and space) through education and the development of recommended practices and standards. IEST is an ANSI-accredited standards-developing organization; secretariat of ISO/TC 209 Cleanrooms and associated controlled environments; administrator of the ANSI-accredited US TAG to ISO/TC 209; and a founding member of the ANSI-accredited US TAG to ISO/TC 229 Nanotechnologies.

Visit www.iest.org

May 27, 2008 — ATLANTA, GA — Proper air quality is essential for general health and well-being in indoor spaces. Recognizing this, most people will take steps to address air quality in their homes and workplaces, but what about when on board an airplane when passengers have no control in a very high-density environment?

The American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE) addresses air cabin air quality in its new Standard 161-2007, Air Quality Within Commercial Aircraft. The standard, which covers issues such as temperature, cabin pressure, air contaminants and ventilation rates, can be voluntarily adopted by individual airlines or the Federal Aviation Administration (FAA), or advocated for by airline passenger and employee groups.

“Compliance with this standard will go a long ways toward ensuring good air quality for passengers and crews,” says Byron Jones, chair of the committee that wrote the standard. “Aircraft passengers and crew make up a wide cross-section of the general population, ranging from the very young to the very old, from the healthy to infirm. And unlike many other indoor environments, occupants do not have the ability to remove themselves from the environment, which is at a lower pressure and relative humidity than that found in many other environments. Standard 161 will help create a healthier, more enjoyable ride for the great variety of passengers on board.”

The standard also addresses chemical, physical, and biological contaminants that could affect air quality as well. Methods of testing are provided for ensuring compliance with the standard’s requirements.

Standard 161 applies to commercial passenger air-carrier aircraft carrying 20 or more passengers. It is intended to apply to all phases of flight operations and to ground operations when the aircraft is occupied by passengers or crew members.

About ASHRAE
ASHRAE, founded in 1894, is an international organization of 50,000 persons. ASHRAE fulfills its mission of advancing heating, ventilation, air conditioning, and refrigeration to serve humanity and promote a sustainable world through research, standards writing, publishing, and continuing education.

Visit www.ashrae.org

May 19, 2008 — /PRNewswire/ SAN JOSE, CA — Novellus Systems today announced two new industry-leading dry strip and clean systems, each targeting different photoresist removal requirements at fabs and foundries worldwide.

The G400(TM) and GxT(TM) are built upon Novellus’ production-proven, market-leading GAMMA(R) platform. The new tools address high throughput and low defectivity requirements for flash, DRAM, and logic applications. Both systems have shipped to customers, with the first G400 going to a large Asian memory manufacturer and the GxT placed at multiple large foundries in Asia.

“With IC manufacturing becoming more complex, there is a clear need for specialized, dedicated tools like the G400 and GxT which have been optimized to meet diverging customer needs. Strip systems in cost-sensitive memory applications need to deliver the highest levels of productivity while providing the lowest cost of ownership. Logic applications, on the other hand, are driven by advanced technology requirements, with a need to deliver low silicon loss, ultra-low defectivity and critical clean applications,” says Kevin Jennings, vice president and general manager of Novellus’ Surface Integrity Group. “The introduction of these tools will further extend our leadership in the market for strip and clean systems.”

Targeting bulk strip and high-dose implant strip (HDIS) applications primarily used in large DRAM and flash memory fabs, the G400 is the industry’s highest throughput ashing system. Enhanced source technology combined with faster wafer heating for higher ash rates enables the system to simultaneously deliver over 400 wafers per hour for bulk strip applications and 300 wafers per hour for implant strip applications. The G400 combines a new high-rate ashing technology with an optimized system design to provide up to a 25 percent productivity gain compared to prevailing industry standards.

Targeting critical logic processes that require low silicon loss and ultra-low defectivity, the GxT provides advanced capabilities for both demanding strip applications (including both HDIS and super-HDIS) and BEOL clean applications.

The GxT takes advantage of Novellus’ production-proven multi-station sequential processing (MSSP) architecture, offering multiple process zones that provide the flexibility to handle complex recipes and chemistries. The system’s SmartFlow gas distribution technology supports individual station-by-station control of both oxidizing and reducing chemistries.

Key to the system’s success is its ability to support higher-temperature bulk applications, lower-temperature HDIS and advanced cleaning processes simultaneously on the same platform. These lower-temperature applications are integral to providing low silicon loss while ensuring high throughput with low cost of ownership.

Both the G400 and the GxT are built on the highly successful GAMMA platform, which is deployed at eight of the top 10 semiconductor manufacturers, spans four technology nodes, and is in use today for 32-nm pilot production. The continuously evolving GAMMA platform enabled Novellus to achieve significant gains in market share in 2007, according to reports from both Dataquest and VLSI Research. Its most recent version, the GAMMA Express, is a market leader in 300mm photo resist removal at the 65-nm and 45-nm nodes, and it is qualified at multiple top DRAM, flash, logic, and foundry semiconductor manufacturers.

About Novellus
Novellus Systems, Inc. is a leading provider of advanced process equipment for the global semiconductor industry. The company’s products deliver value to customers by providing innovative technology backed by trusted productivity. An S&P 500 company, Novellus is headquartered in San Jose, Calif. with subsidiary offices across the globe.

Source: Novellus Systems, Inc.

Visit www.novellus.com

May 19, 2008 — /PRNewswire/ FAIR LAWN, NJ — Tasker Products Corp., a distributor and marketer of proprietary technology effective in inhibiting pathogenic bacteria, today announced that it has received authorization from the Food Safety and Inspection Service (FSIS) of the United States Department of Agriculture (USDA) to market its Tasker Clear product as a processing aid in the red meat and pork processing industries. This comes on the heels of receiving similar authorization to market Tasker Clear to the poultry industry.

Tasker Clear is a liquid application that aids in the control of pH levels in water used in various protein (meat, poultry and pork) processing. The product is considered “safe and suitable,” according to FSIS, when used in the processing of red and white meats. Tasker Clear, when used in combination with chlorine as an acidifier, becomes an acidified chlorine, which is a safe and widely used antimicrobial. The company intends to market Tasker Clear in multiple sections of meat processing, from pre-carcass treatment to rapid chilling and in the ensuing “secondary processing” sections during which meat is separated into primal sections, finished product, tenderized, marinated, or ground.

Lanny Dacus, Tasker’s president and CEO, comments, “This authorization extends Tasker marketing efforts to include red meat, poultry and pork processors, while working through testing processes of Tasker Blue for other meat processing applications. We have already received an order for Tasker Clear from a red meat processor. Tasker Clear applications for red meat and poultry processing are effective and cost competitive. Because of the existing worldwide use of acidifiers in meat processing, we intend to expand our market boundaries beyond the United States. We also intend to vertically expand our line of applications similar to what we did with our dairy line of products.”

Dacus adds, “It is estimated that the meat and pork market opportunity alone exceeds $200 million in annual revenue in the United States. As we announced yesterday, our goal is to establish Tasker products as a leading player in the food processing and dairy industries. Our goal is to gain a 20% market share in each category we enter.”

About Tasker Products
Tasker is a manufacturer, distributor and marketer of acid-based eco-chemistry products. The company currently markets Unifresh(R) Footbath products for dairy cows, Tasker Blue(R) and Tasker Clear, antibacterial solutions for use in processing poultry, and Pacific Blue(TM) Seafood Spray, an antibacterial spray for retail seafood counters. Tasker Products Corp. is headquartered in Fair Lawn, NJ.

Source: Tasker Products Corp.

Visit www.taskerproducts.com

May 12, 2008 — /PRNewswire/ — INDIANAPOLIS, IN — Eli Lilly and Company announced today completion of the final phase of its $1 billion effort to further strengthen the company’s biotechnology research and development capabilities.

At a ceremony at its Indianapolis operations, Lilly officials, along with participation by Indianapolis Mayor Gregory Ballard, dedicated the final and largest phase of the company’s biotech operations – the Bioproduct Research and Development Laboratory (known as K362), which has now become Lilly’s headquarters for biotechnology research and development.

The 475,000 sq. ft., four-story laboratory is home to nearly 500 scientists and research support staff who are conducting cutting-edge research in molecular and cell biology, analytical science, and engineering. In these labs, Lilly scientists will research and develop the next generation of biopharmaceuticals that will follow currently marketed Lilly biopharmaceuticals such as Xigris(R) for the treatment of severe sepsis and Forteo(R) for the treatment of osteoporosis.

Biopharmaceutical products differ from traditional chemical-based pharmaceuticals in that scientists utilize cellular or biocellular processes to make biopharmaceuticals rather than relying on chemical processes.

The final phase dedicated today marks the completion of the third of three facilities that make up Lilly’s Indianapolis-based biotechnology complex. The first phase of construction, completed in October 2006, was a state-of-the-art bioproduct pilot manufacturing plant (known as K360). The 250,000 sq. ft. facility employs scientists and engineers who model manufacturing processes to eventually scale up commercial production of future Lilly biopharmaceuticals.

The staff in K360 helps ensure a seamless transition from development to full-scale manufacturing – a notoriously complex process in biotechnology – giving Lilly speed to market and cost advantages over its biotech competitors.

The second phase, also opened in the fall of 2006, is a 10,000 sq. ft. research support facility (known as K361) that houses support staff members. In total, buildings K360 and K361 are home to nearly 300 scientists and support staff.

“This completed biotechnology complex gives us the ability to capitalize on the synergies of being colocated with our drug discovery in Indianapolis,” says Steven Paul, M.D., executive vice president of science and technology and president of Lilly Research Laboratories. “This is a state-of-the-art facility that allows us to move products through the pipeline with increased efficiencies, high quality, and cost savings. This facility basically allows us to quadruple the throughput of our biotechnology pipeline.”

“The company’s investment in these facilities gives Lilly a line of sight from discovery through development and into manufacturing, uniquely positioning us as a biopharmaceutical leader in the industry,” says Bill Heath, PhD, vice president of product research and development.

“Lilly is an incredible asset to our community,” says Mayor Greg Ballard. “The company’s decision to keep nearly 800 high-tech, high-paying jobs in Indianapolis is tremendous for our city and underscores the growing life sciences sector here in Indiana. As a Fortune 500 company, Lilly has played and will continue to play an important role in that sector’s growth in Indianapolis.”

Lilly has been a leader in biopharmaceuticals since 1922, when the company was the first to make and market insulin. Today Lilly is the fifth largest biotechnology company in the world as measured by total sales. Approximately 30 percent (eight medicines) of Lilly’s total drug portfolio are biotech medicines in several therapeutic categories, representing about $4.4 billion of the company’s 2007 sales. Biotech medicines also represented one-third of the company’s drug pipeline at the end of 2007.

The construction of the three buildings in Indianapolis that make up the Biotechnology Complex, along with Lilly’s acquisition in 2004 of Applied Molecular Evolution – a San Diego-based operation that conducts protein optimization research accounts for a total biotech capital investment of approximately $1 billion.

On April 9, 2008, Lilly Chief Executive Officer John Lechleiter traveled to Ireland for the groundbreaking of the Kinsale biopharmaceutical manufacturing facility. The Kinsale facility will scale up the manufacturing of the biopharmaceuticals discovered in Indianapolis to treat illnesses such as cancer, diabetes and Alzheimer’s disease. The 400 million Euro investment will bring an additional 200 jobs to the area. Lilly currently employs more than 400 people at the Kinsale site, which the company opened in 1981.

About Lilly
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, IN, Lilly provides answers – through medicines and information – for some of the world’s most urgent medical needs.

Source: Eli Lilly and Co.

Visit www.lilly.com